Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine.

ABSTRACT: Neurospagioma, arising from different glial cells such as astrocytes, oligodendrocytes, and ependymal cells, stands as the prevalent intracranial tumor within the central nervous system. Among its variants, glioblastoma (GBM) represents the most aggressive form, characterized by a notably high occurrence rate and a discouragingly low survival prognosis. The formidable challenge posed by glioblastoma underscores its critical importance as a life-threatening ailment. Currently, clinical approaches often involve surgical excision along with a combination of radiotherapy and chemotherapy. However, these treatments frequently result in a notable recurrence rate, accompanied by substantial adverse effects that significantly compromise the overall prognosis. Hence, there is a crucial need to inve

SUBMITTER: Qian D 

PROVIDER: S-EPMC10771477 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature